Human CD20/MS4A1 VLP (CD2-HM123)

Produktübersicht

• Artikelname: Human CD20/MS4A1 VLP (CD2-HM123)
• Artikelnummer: KAB-CD2-HM123
• Hersteller Artikelnummer: CD2-HM123
• Alternativnummer: KAB-CD2-HM123-100UG
• Hersteller: KactusBio
• Kategorie: Sonstiges
• Spezies Reaktivität: Human
• Alternative Synonym: MS4A1, CD20, MS4A-1, B1, Bp35, CD20 receptor, CD20S7, CVID5, LEU-16, Ly-44, MS4A2, S7

Produktbeschreibung

Recombinant Human CD20/MS4A1 VLP is expressed from HEK293.It contains Met1-Pro297 (It may have cross reaction with anti-His antibody).

Produkteigenschaften

• Molekulargewicht: The target protein has a predicted MW of 34.3 kDa.
• UniProt: P11836
• Puffer: Supplied as 0.22µm filtered solution in PBS, 300mM L-arginine (pH 7.4). <RED>Notice: If you need it for immunization, water-soluble adjuvant is recommended.</RED&gt
• Expression System: HEK293
• Reinheit: > 95% as determined by HPLC
• Formulierung: Liquid
• Sequenz: Met1-Pro297
• Target-Kategorie: CD20/MS4A1

Bilder

The purity of Human CD20 VLP is greater than 95% as determined by SEC-HPLC.

Immobilized Human CD20 VLP at 5ug/ml (100ul/Well) on plate on the plate. Dose response curve for Rituximab, hFc Tag with the EC50 of 8.6ng/ml determined by ELISA (QC Test).

Immobilized Human Human CD20 VLP at 5ug/ml (100ul/well) on the plate. Dose response curve for Ofatumumab, hFc Tag with the EC50 of 3.8ng/ml determined by ELISA.

Immobilized Human Human CD20 VLP at 5ug/ml (100ul/well) on the plate. Dose response curve for Obinutuzumab, hFc Tag with the EC50 of 4.0ng/ml determined by ELISA.